pyrvinium has been researched along with Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, J; He, TC; Reid, RR | 1 |
| Abdollahi, E; Caraglia, M; Ghasemi, F; Momtazi-Borojeni, AA; Sahebkar, A | 1 |
| Abreu, MT; Astudillo, L; Capobianco, AJ; Chen, X; Cobb, MH; Doundoulakis, T; Fei, DL; Guerra, ML; Jin, K; Kirkbride, KC; Lee, E; Li, B; Long, J; Marchetti, F; Neitzel, LR; Nguyen, DM; Orton, D; Robbins, DJ; Rodriguez-Blanco, J; Sands, LR; Shen, C; Thorne, C; Wang, Z; Zaias, J | 1 |
| Chen, Y; Deng, L; Edwards, CK; Huang, C; Lei, Y; Li, J; Li, Y; Liu, R; Liu, Y; Lu, Y; Wei, Y; Yuan, K | 1 |
| Liu, Y; Lv, J; Sup Shim, J; Wu, C; Yang, EJ | 1 |
| Esumi, H; Kita, K; Tomitsuka, E | 1 |
| Emami, S; Ouelaa-Benslama, R | 1 |
4 review(s) available for pyrvinium and Neoplasms
| Article | Year |
|---|---|
The novel role of pyrvinium in cancer therapy.
Topics: Animals; Antineoplastic Agents; Autophagy; Humans; Neoplasms; Neoplastic Stem Cells; Pyrvinium Compounds; Signal Transduction | 2018 |
Revisiting Non-Cancer Drugs for Cancer Therapy.
Topics: Antineoplastic Agents; Disulfiram; Doxycycline; Drug Repositioning; High-Throughput Screening Assays; Humans; Mebendazole; Neoplasms; Pyrvinium Compounds; Triclosan | 2016 |
The NADH-fumarate reductase system, a novel mitochondrial energy metabolism, is a new target for anticancer therapy in tumor microenvironments.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Energy Metabolism; Gene Expression Regulation, Neoplastic; Humans; Mitochondria; Models, Biological; Neoplasms; Oxidoreductases Acting on CH-CH Group Donors; Oxygen; Phosphorylation; Pyrvinium Compounds | 2010 |
Pinworm and TNKS inhibitors, an eccentric duo to derail the oncogenic WNT pathway.
Topics: Animals; Anthelmintics; Enterobius; Humans; Neoplasms; Pyrvinium Compounds; Tankyrases; Wnt Signaling Pathway | 2011 |
3 other study(ies) available for pyrvinium and Neoplasms
| Article | Year |
|---|---|
Pyrvinium doubles against WNT-driven cancer.
Topics: beta Catenin; Humans; Neoplasms; Pyrvinium Compounds; Wnt Signaling Pathway | 2022 |
Differential abundance of CK1α provides selectivity for pharmacological CK1α activators to target WNT-dependent tumors.
Topics: Animals; Antineoplastic Agents; Benzoates; Casein Kinase Ialpha; Enzyme Activation; Enzyme Activators; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Neoplasm Metastasis; Neoplasms; Organ Culture Techniques; Phosphorylation; Pyrvinium Compounds; Signal Transduction; Surface Plasmon Resonance; Wnt Proteins; Wnt Signaling Pathway; Xenograft Model Antitumor Assays; Xenopus laevis | 2017 |
Pyrvinium targets autophagy addiction to promote cancer cell death.
Topics: AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Autophagy; Cell Line; Deoxyglucose; Female; HCT116 Cells; HEK293 Cells; HeLa Cells; Humans; Mice; Mice, Inbred BALB C; Microtubule-Associated Proteins; Neoplasms; Pyrvinium Compounds; TOR Serine-Threonine Kinases; Transplantation, Heterologous; Zebrafish | 2013 |